Veritas Intercontinental

HealthcareSeries BMadrid, Spainveritasint.com

Latest round

Series B

Last raised

Oct 2020

Total raised

$21M

Investors

3

About Veritas Intercontinental

Founded in 201 and based in Madrid, Spain, Veritas Intercontinental is the international subsidiary of Veritas Genetics, which operates genetic testing platform intended to empower people about the quality and length of life. The company co-founded by Javier de Echevarría, Luis Izquierdo López, and Vincenzo Cirigliano and as of October 2020, the operates in Europe, Latin America, Middle East, and Japan. In October 2020, the company was received EUR 20 million from Charme Capital Partners and Amadeus Capital. The company offers genetic testing solutions such as mygenome, myprenatal, mynewbornDNA, mycancerrriskDNA, mydiagnostic, and covid19, intended to support clinical researchers and physicians by offering a screening test for hereditary cancer risk. The company generated by offering genetic tests and healthcare counseling. Veritas Intercontinental plans to expand its international expansion and to develops new operational and technological capabilities.

Who invested in Veritas Intercontinental

3 investors across 2 rounds

See all investors in Veritas Intercontinental

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 15, 2020

    Amount

    $5.9M

    Investors

    Locked

  2. Series A

    Jul 14, 2018

    Amount

    $15M

    Investors

    Locked

Questions about Veritas Intercontinental

Who invested in Veritas Intercontinental?

Veritas Intercontinental has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Veritas Intercontinental raised?

Veritas Intercontinental has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Veritas Intercontinental last raise money?

Veritas Intercontinental's most recent round on record is a Series B, in Oct 2020.

What does Veritas Intercontinental do?

Founded in 201 and based in Madrid, Spain, Veritas Intercontinental is the international subsidiary of Veritas Genetics, which operates genetic testing platform intended to empower people about the quality and length of life.

Where is Veritas Intercontinental headquartered?

Veritas Intercontinental is headquartered in Madrid, Spain.

Which VCs invest in companies like Veritas Intercontinental?

Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Veritas Intercontinental's stage. Their profiles are linked below.

Raising like Veritas Intercontinental? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.